Tottenham are making a “surprise” move for Celtic midfielder Arne Engels, while a goalkeeper swap could be on the cards, ...

Is there a better way to brush up on your film and TV series trivia knowledge, than trying to think of as many characters you can in a certain category? This is an ultimate list of best characters ...

Massimiliano Allegri is not seeking redemption at Napoli despite a tough end to his second spell with AC Milan. Allegri was ...

Jude Bellingham has been one of England's most important players at the 2026 FIFA World Cup, helping the Three Lions into the ...

SK Hynix (SKHY) completed a $26.5B ADR debut, the largest-ever U.S. IPO by a foreign company. The ADR listing could drive SKHY to trade at a premium and potentially re-rate its Korean shares closer to ...

From powerful, data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more ...

Last week, Channel 5 screened Riptide, a 2022 drama featuring Jo Joyner, offering a second chance for those who missed its original broadcast, while this week sees the return of L ...

undefined quarterly & annual earnings - Track stocks financial health, Earnings performance, key metrics like revenue, net profit, and growth trends. Compare stock's quarter on quarter metrics such as ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

This trial is looking at a new drug called TT-702 for solid tumours. It is for people who have: cancer that has spread elsewhere in the body. This is advanced or metastatic cancer. no standard ...